Vildagliptin 50 mg bid

DRUG3 trials

Sponsors

Novartis, Merck Sharp & Dohme LLC, First Affiliated Hospital, Sun Yat-Sen University

Conditions

Parkinson's DiseaseType 2 Diabetes Mellitus

Phase 1

A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)

CompletedNCT01582308

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2012-06-21End: 2012-12-14Updated: 2017-05-30

Phase 3

Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy

CompletedNCT00822211

NovartisType 2 Diabetes Mellitus

Start: 2008-12-31End: 2009-12-31Updated: 2016-11-18

Unknown Phase

Clinical Trial of Vildagliptin in Early Parkinson's Disease

Not yet recruitingNCT06951334

First Affiliated Hospital, Sun Yat-Sen UniversityParkinson's Disease

Start: 2025-06-01End: 2026-12-31Target: 66Updated: 2025-04-30